-
June 13, 2022
Colon Cancer Treatment & Management Bookmark
George Lundberg, MDWritten for physicians and healthcare professionals, Medscape provides this trustworthy, encyclopedic resource for treating and managing metastatic colorectal cancer.
.
-
June 13, 2022
Latest Evidence on Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer: A 2022 Update Bookmark
George Lundberg, MD
This scientific research paper from Critical Reviews in Oncology/Hematology discusses current options for treatments known as immune checkpoint inhibitors for people with advanced colorectal cancer..
-
June 10, 2022
Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer Bookmark
George Lundberg, MDThis 2022 scientific review article from the Journal of the Advanced Practitioner in Oncology discusses new treatment options for people with advanced endometrial cancer.
.
-
June 10, 2022
NCI Overview of Uterine Cancer Bookmark
George Lundberg, MDThe National Cancer Institute provides this online overview of uterine cancer that is up-to date, comprehensive, and written specifically for patients.
.
-
June 10, 2022
NCCN Guidelines for Patients: Endometrial Cancer Bookmark
George Lundberg, MDEndometrial cancer is the most common kind of uterine cancer. The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their most recent guideline for people with endometrial cancer.
.
-
April 26, 2022
Can Immunotherapy Be Effective for Brain Cancer?
With:Immunotherapy has reshaped the cancer treatment landscape. This type of treatment boosts the immune system to fight cancer. However, for people with advanced brain cancer, immunotherapy options remain slim. Here, our Curious Dr. George asks Cancer Commons Scientist Matt Warner, PhD, about the challenges and future potential of immunotherapy for brain cancer. Curious Dr. George: An accomplished molecular oncologist, you have now helped many… Read more »
-
April 20, 2022
Triplet Combination Improves Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer Bookmark
George Lundberg, MDMetastatic carcinoma of the prostate is fatal, but a 3-drug combination treatment can prolong life substantially, according to new clinical trial results outlined by The ASCO Post.
.
-
April 6, 2022
Essential Breast Cancer Treatment Trends in 2022: Webinar Highlights
Sarah StanleyWomen with breast cancer often face an overwhelming amount of information to sort through and decisions to make. Whether newly diagnosed or starting a next step in treatment, they may wonder: What does the latest research say about my type of breast cancer? Should I enroll in a clinical trial? How do I know if I’m receiving my best-possible treatment? Every day, Cancer Commons… Read more »
-
March 8, 2022
Hepatocellular Carcinoma in 2021: An Exhaustive Update Bookmark
George Lundberg, MDThis exhaustive scientific review was published by Cureus in 2021, but remains relevant now. It explores current molecular understanding of hepatocellular carcinoma—the most common type of cancer that starts in the liver—as well as a very large range of diagnostic and treatment options.
.
-
February 18, 2022
Palliative Care Options for a Young Adult Patient with a Diffuse Intrinsic Pontine Glioma Bookmark
George Lundberg, MDThis clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.
.